Explorer les evidences

70,8 %Among IgM-positive participants, 70.8% (34/48) had detectable HEV RNA.

Nigeriahepatitis E viruspublié 2026Journal of infection and public healthPubMeddocument de 9 observations

58,3 %Among respondents who would accept the HPV vaccine for their female adolescents, 58.3% cited prevention of HPV transmission as the commonest reason.

Nigeriainfection à HPVobservé 2023publié 2025The Pan African medical journalPubMeddocument de 10 observations

89,7 %Out of 378 participants, 339 (89.7%) were using hydroxyurea while 39 (10.3%) had stopped using hydroxyurea at the time of the study.

Nigeriadrépanocytosepublié 2022Frontiers in geneticseurope_pmcdocument de 10 observations

73,6 %The tuberculosis-specific service readiness index was 73.6% in Anambra state.

Nigeriatuberculosepublié 2020BMC health services researchPubMeddocument de 14 observations

98,6 %Overall retention to care was 98.6%.

NigeriaVIH/sidaobservé May 2022 to May 2023publié 2026BMC public healthPubMeddocument de 9 observations

268 cells_per_mm3The mean CD4 count at enrollment in care was 268 ± 23.7 cells per mm³.

NigeriaVIH/sidapublié 2020AIDS research and therapyPubMeddocument de 12 observations

55 %Among 108 children who completed the feasibility trial for managing severe acute malnutrition in older children with sickle cell anemia in Nigeria, 55% (n = 59) had low food security and 34% (n = 37) had very low food security.

Nigeriadrépanocytose · malnutritionpublié 2025Pediatric blood & cancerPubMeddocument de 4 observations

3,37 aorSpousal HIV-positive status was associated with improved HRQOL (adjusted odds ratio = 3.37, 95% confidence interval: 1.46–7.74).

NigeriaVIH/sidapublié 2020BMC public healthPubMeddocument de 11 observations

53 %Among asymptomatic malaria infections in adolescents in Ibadan, Plasmodium malariae accounted for 53% of cases.

Nigeriapaludismeobservé 2016publié 2022International journal for parasitologyPubMeddocument de 14 observations

0,3 %State-level HIV prevalence in Nigeria ranged from 0.3% to 4.3% based on data from the Nigeria HIV/AIDS Indicator and Impact Survey (NAIIS) conducted from July to December 2018.

NigeriaVIH/sidaobservé 2018publié 2022PloS onePubMeddocument de 5 observations

35,6 %Treatment with ciprofloxacin 160 mg kg-1 alone suppressed parasitaemia by 35.6%.

Nigeriapaludismepublié 2015Parasitologyeurope_pmcdocument de 9 observations

90 womenWe screened cervical samples from 90 women with possible HPV infections collected in two regional hospitals in Nigeria.

Nigeriainfection à HPVpublié 2023Virology journalPubMeddocument de 8 observations

27,6 %Asymptomatic malaria parasitaemia was observed in 27.6% of children under 5 years.

Nigeriapaludismepublié 2020West African journal of medicinePubMeddocument de 6 observations

40 %The proportion of viral non-suppressed participants among youth living with HIV in Nigeria was 40% at baseline.

NigeriaVIH/sidaobservé 2021publié 2025AIDS and behaviorPubMeddocument de 2 observations

2,7 %The prevalence of Metabolic Syndrome among normal-weight adolescents in Mushin Local Government, Lagos was 2.7%.

Nigeriasyndrome métaboliquepublié 2024West African journal of medicinePubMeddocument de 5 observations

1,9 %Women aged 15 to 49 years in Nigeria have an HIV prevalence rate of 1.9%.

NigeriaVIH/sidapublié 2022The Pan African medical journalPubMeddocument de 2 observations

500 000 peopleBased on NAIIS results, funds were provided to place an additional 500,000 HIV-positive Nigerians on antiretroviral therapy by the end of 2020.

NigeriaVIH/sidaobservé 2020publié 2021Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 6 observations

11 %Anti-HDV antibody seroprevalence was 11.0% among individuals with hepatocellular carcinoma (HCC) and/or cirrhosis in Nigeria.

Nigeriahepatitis D viruspublié 2026BMC infectious diseasesPubMeddocument de 7 observations

0,4 mmol/LMedian serum magnesium levels were significantly lower in patients with type 2 diabetes mellitus than in controls: 0.40 mmol/L (interquartile range 0.30–0.43) versus 0.88 mmol/L (interquartile range 0.76–1.02).

Nigeriadiabète de type 2PubMeddocument de 7 observations

85 %Eighty five percent (71/84) of the Plasmodium falciparum isolates were resistant in-vitro to chloroquine.

Nigeriapaludismepublié 2008The open tropical medicine journaleurope_pmcdocument de 7 observations

88 %At the 10% threshold, 88% of the poorest quartile of sickle cell disease patients experienced catastrophic expenditure.

Nigeriadrépanocytosepublié 2022PloS onePubMeddocument de 5 observations

43 %43% of the respondents cited lack of a doctor's request as the most common reason for not having undergone cervical screening.

Nigeriacancer du col de l'utéruspublié 2024African health sciencesPubMeddocument de 5 observations

0,5 %The prevalence of HIV in the study population was 0.5%.

NigeriaVIH/sidapublié 2025American journal of clinical pathologyPubMeddocument de 5 observations

6 %Only 6% of women had HIV tests during labour.

NigeriaVIH/sidaobservé 2013publié 2020Journal of biosocial sciencePubMeddocument de 4 observations

0,316 rhoThere was a significant correlation between knowledge and practice of HIV PEP among doctors (Spearman's rho = 0.316, p < 0.05).

NigeriaVIH/sidapublié 2020West African journal of medicinePubMeddocument de 6 observations